BeStock  
股票 › 生物科技 › ATTO

Attovia 制药 ATTO

美股市值排名 #3465生物科技
$15.27 +$0.27 (+1.80%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $15.27 0.00%
开盘$14.93
昨收$15.00
当日区间$14.93 – $15.50
成交量218.8K
市值$697.09M
市盈率(TTM)–
股息率–

股权结构与仓位

谁在持有、谁在做空,以及大资金的流向

机构持股比例50.6%+50.63 个百分点,较上季度
持仓机构数14+14 ,较上季度
内部人近期交易17次买入 / 0次卖出净买入
空头持仓比例3.18% 占流通股回补天数 3.5 · 截至 15 Oct 2026
卖空成交量占比21.8%近5日成交量平均占比

卖空成交量占当日成交量比例

11%20%29%39%Sep '26Oct '26Nov '26

大单净流入,近20个交易日

大单买入减卖出的净额(美元)。该窗口期内:−$3.47M(5个净流入日,15个净流出日)。

按单量净流入,近20个交易日

−$2.9M超大单−$555.1K大单−$1.1M中单−$4.7M小单

超大单/大单近似机构级别交易;中单/小单近似散户级别交易。各档买入减卖出净额,按窗口期累计。

已披露的前五大股东合计持有42.8%的流通股。

最大股东

  • Frazier Life Sciences Management, LP15.27%
  • venBio LLC9.16%
  • Alamar Biosciences, Inc.7.07%
  • Deep Track Capital, LP7.03%
  • Goldman Sachs Asset Management, L.P.4.31%
  • Sanofi2.37%
  • Redmile Group, LLC2.15%
  • Vanguard Capital Management, LLC1.95%

按投资者类型

  • VC/PE Fund31.45%
  • Public Company10.47%
  • Mutual Fund6.56%
  • Hedge Fund2.15%
  • Individual/Insider1.58%

过去5次双周报告中(14 Aug 2026至15 Oct 2026),空头持仓占流通股比例已从1.19%升至3.18%。

近期机构持仓变动

股东类型期间持股变动新持股比例
Charles Schwab Investment Management Mutual Fund 2026/Q3 +100,603 0.2%
Vanguard Capital Management, LLC Mutual Fund 2026/Q3 +891,189 2.0%
Vanguard Portfolio Management, LLC Mutual Fund 2026/Q3 +20,495 0.0%
Vanguard Capital Management, LLC Mutual Fund 2026/Q3 +90,644 0.2%
Hartford Funds Management Company, LLC Mutual Fund 2026/Q3 +12,400 0.0%
Vanguard Portfolio Management, LLC Mutual Fund 2026/Q3 +2,430 0.0%
Wellington Management Group Mutual Fund 2026/Q3 +1,800 0.0%
Vanguard Global Advisers, LLC Mutual Fund 2026/Q3 +891 0.0%
Deep Track Capital, LP VC/PE Fund 2026/Q3 +3,207,138 7.0%
Frazier Life Sciences Management, LP VC/PE Fund 2026/Q3 +6,968,703 15.3%
venBio LLC VC/PE Fund 2026/Q3 +4,181,367 9.2%
Sanofi Public Company 2026/Q3 +1,082,855 2.4%
Redmile Group, LLC Hedge Fund 2026/Q3 +982,854 2.2%
Alamar Biosciences, Inc. Public Company 2026/Q3 +3,229,279 7.1%
Goldman Sachs Asset Management, L.P. Mutual Fund 2026/Q3 +1,967,074 4.3%

按报告期列出的机构买卖动态,变动幅度从大到小排列。

内部人交易

日期内部人职位交易类型股数价格交易后持股
5 Aug 2026 Sanofi Private Acquisition +300,000 $17.00 1,082,855
5 Aug 2026 Sanofi Derivative Exercise and Retained +782,855 – 1,082,855
5 Aug 2026 Redmile Group, LLC Private Acquisition +200,000 $17.00 982,854
5 Aug 2026 Redmile Group, LLC Derivative Exercise and Retained +782,854 – 982,854
5 Aug 2026 venBio LLC Private Acquisition +382,352 $17.00 4,181,367
5 Aug 2026 venBio LLC Derivative Exercise and Retained +3,799,015 – 4,181,367
5 Aug 2026 Deep Track Capital, LP Derivative Exercise and Retained +1,957,138 – 1,957,138
5 Aug 2026 Frazier Life Sciences Management, LP Private Acquisition +588,235 $17.00 6,154,213
5 Aug 2026 Frazier Life Sciences Management, LP Derivative Exercise and Retained +5,490,629 – 6,154,213
4 Aug 2026 Goldman Sachs Asset Management, L.P. Open Market Derivative Acquisiti +105,807 – 105,807
3 Aug 2026 Sanofi Initial Statement of Beneficial +0 – 782,855
3 Aug 2026 Mitchell Gold Independent Director Other Derivative Acquisition +27,000 $17.00 27,000
3 Aug 2026 Mitchell Gold Independent Director Initial Statement of Beneficial +0 – 19,913
3 Aug 2026 Angie You Independent Director Other Derivative Acquisition +27,000 $17.00 27,000
3 Aug 2026 John Smither Independent Director Initial Statement of Beneficial +0 – 72,792
3 Aug 2026 Hubert Chen Chief Medical Officer Other Derivative Acquisition +140,000 $17.00 140,000
3 Aug 2026 Broad Street Principal Investments, L.L.C. Initial Statement of Beneficial +0 – 855,179
3 Aug 2026 Tao Fu Chief Executive Officer Other Derivative Acquisition +538,300 $17.00 538,300
3 Aug 2026 Tao Fu Chief Executive Officer Initial Statement of Beneficial +0 – 803,436
3 Aug 2026 Steven Chan Chief Financial Officer Other Derivative Acquisition +140,000 $17.00 140,000

数据来自Form 4/Form 144申报文件。负数为减持(出售、赠予或代扣税款股份),正数为增持。

空头持仓(按报告期)

报告日期空头股数占流通股比例回补天数
15 Oct 2026 1,453,089 3.2% 3.5
30 Sep 2026 1,649,612 3.6% 3.0
15 Sep 2026 831,090 1.8% 4.0
31 Aug 2026 648,541 1.5% 3.1
14 Aug 2026 511,865 1.2% 1.0

讨论区

暂无评论——快来第一个聊聊 ATTO。

登录后参与讨论。

Scroll to Top